AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
ent views and/or expectations of AKELA Pharma Inc. withrespect to its performance business and future events. Such statements aresubject to a number of risks uncertainties and assumptions. Actual resultsand events may vary significantly.
Date:9/5/2007